Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2021. Module: SNOMED CT core
Descriptions:
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| antigène de la protéine de spicule recombinante du coronavirus 2 du syndrome respiratoire aigu sévère (substance) | est un(e) (attribut) | antigène de la protéine du coronavirus 2 du syndrome respiratoire aigu sévère (substance) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| COVID-19 recombinant spike protein unspecified | a pour principe actif (attribut) | True | antigène de la protéine de spicule recombinante du coronavirus 2 du syndrome respiratoire aigu sévère (substance) | Inferred relationship | Some | 1 |
| COVID-19 NUVAXOVID NOV | a pour principe actif (attribut) | True | antigène de la protéine de spicule recombinante du coronavirus 2 du syndrome respiratoire aigu sévère (substance) | Inferred relationship | Some | 1 |
| Medgen-Dynavax-NIAID COVID-19 recombinant spike protein vaccine (real medicinal product) | a pour principe actif (attribut) | True | antigène de la protéine de spicule recombinante du coronavirus 2 du syndrome respiratoire aigu sévère (substance) | Inferred relationship | Some | 1 |
| SpikoGen COVID-19 recombinant spike protein vaccine (real medicinal product) | a pour principe actif (attribut) | True | antigène de la protéine de spicule recombinante du coronavirus 2 du syndrome respiratoire aigu sévère (substance) | Inferred relationship | Some | 1 |
| ZIFIVAX COVID-19 recombinant spike protein vaccine (real medicinal product) | a pour principe actif (attribut) | True | antigène de la protéine de spicule recombinante du coronavirus 2 du syndrome respiratoire aigu sévère (substance) | Inferred relationship | Some | 1 |
| EpiVacCorona COVID-19 recombinant spike protein vaccine (real medicinal product) | a pour principe actif (attribut) | True | antigène de la protéine de spicule recombinante du coronavirus 2 du syndrome respiratoire aigu sévère (substance) | Inferred relationship | Some | 1 |
| Soberana 02 COVID-19 recombinant spike protein vaccine (real medicinal product) | a pour principe actif (attribut) | True | antigène de la protéine de spicule recombinante du coronavirus 2 du syndrome respiratoire aigu sévère (substance) | Inferred relationship | Some | 1 |
| COVOVAX COVID-19 recombinant spike protein vaccine (real medicinal product) | a pour principe actif (attribut) | True | antigène de la protéine de spicule recombinante du coronavirus 2 du syndrome respiratoire aigu sévère (substance) | Inferred relationship | Some | 1 |
| Abdala COVID-19 recombinant spike protein vaccine (real medicinal product) | a pour principe actif (attribut) | True | antigène de la protéine de spicule recombinante du coronavirus 2 du syndrome respiratoire aigu sévère (substance) | Inferred relationship | Some | 1 |
Reference Sets
Canada English language reference set (foundation metadata concept)
Antigen codes for vaccines reference set (foundation metadata concept)